Reza Shojaei on Leadership in the Blood and Plasma Sector
Reza Shojaei, Chief Operating Officer at Canadian Plasma Resources, shared on LinkedIn:
”Leadership in the blood and plasma sector is unlike leadership anywhere else.
Here, every operational decision can ripple all the way to a hospital bed.
Every delay, deviation, or missed opportunity has human consequences.
In most industries, leaders pursue growth. In the blood and plasma industry, we pursue trust.
In the latest edition of Blood and Plasma Pulse, we explore:
- Why leadership in blood organizations demands a unique blend of science, empathy, and regulation
- How to balance innovation with compliance
- The hidden weight of decision-making in a high-stakes environment
- Practical tips for leading with purpose, resilience, and data-driven confidence
Whether you lead a blood or plasma collection center, a quality team, or a donor engagement initiative, this piece will resonate with the realities you face every day.
Because here, leadership isn’t about control, it’s about custodianship of life and trust.”
Read the full issue here.
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial